Working Groups
Details
ILCCO is organized in project groups that promote collaborative projects in specific areas of lung cancer research. Participation in all project groups is open to all ILCCO members. Members who are interested in participating in working group activities, please contact the project coordinators.
| Project groups | Current Coordinators | Projects |
| Genetic Susceptibility |
Margaret Spitz, Paul Brennan Simone Benhamou, Rayjean Hung, Chris Amos |
(i)Pooled analysis on DNA repair pathway
(see details) published, 2008 (ii) Coordinated genotyping of top 10 variants (see details) published 2010 (iii) Replications of loci identified from GWAS of lung cancer (see details) published 2010 |
| Young onset and Family History |
Michele Cote, Ann Schwartz, Carol Etzel, Rayjean Hung | Pooled analysis on family history (see details) Published 2012 |
| Never smokers |
Zuo-Feng Zhang, Qing Lan |
(i)Pooled Analysis on ETS manuscript in preparation (ii)Pooled Analysis on Indoor Air Pollution (see details)Published, 2010 |
| Light smokers |
Neil Caporaso | Pooled analysis of light smokers: Analysis in planning |
| Alcohol |
Rayjean Hung, Zuo-Feng Zhang | Pooled analysis of alcohol: data analysis ongoing |
| Hormone factors |
Isabelle Stucker, Angela Pesatori | (i)Pooled analysis of reproductive history. Analysis ongoing: (ii)Pooled analysis of hormone related factors: Analysis ongoing |
| Rare Histology |
Paolo Boffetta, Rayjean Hung | Attributable fraction of tobacco on histological subtypes. Published, 2011 |
| Occupation and interaction with genetic factors |
Isabelle Stucker, Paolo Boffetta, David Christiani | Occupational risk factors of lung cancer and their interaction with genetic factors (see details) on going |
| Somatic Mutation |
Pierre Hainaut | In planning stage |
| Statistics | Heike Bickeboller, Carol Etzel | Risk Model Validation (see details) |
| Medical condition |
Rayjean Hung, Eric Duell, Heike Bickeboller, Paolo Boffetta | Pooled analysis of medical condition, NSAID usage and lung cancer risk (see details) published, 2011 and 2012 |
| Survival, Treatment and Pharmacogenetics |
Geoffrey Liu, Maria T.Landi & Xifeng Wu | Genetic, clinical, and environmental determinants of outcome from lung cancer (see details) in planning |
| Statistics |
Heike Bickeboller, Carol Etzel | Risk Model Validation (see details) (see details) in planning |
| Somatic Mutation |
Pierre Hainaut | In planning stage |